fda compounding semaglutide enforcement november 2025 Beyond the Headlines: Warning Letters to GLP-1 Compounders Novo Nordisk expands legal action

Its best for compounding pharmacies to utilize a semaglutide base as well, and to purchase it from an FDA-registered supplier, as those do meet certain federal requirements

GLP-1s and SGLT2s operate through different mechanisms, and when used together , they can offer synergistic benefits , including: Improved blood sugar control Greater weight loss Lower insulin needs Enhanced cardiovascular and kidney protection Combination therapy may be especially helpful for those with multiple metabolic concerns , but it requires close monitoring and medical guidance

Photographer unknown, probably from Karolinska Campus Photo centre

Storage follows standard peptide protocols